Capital International InvestorsCapital International Investors

Institutional investor · Portfolio as of Q2 2025

SEC EDGAR SourceSEC Filings

Top Holdings443 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

BROADCOM INC

151.2M$41.7B7.2%$156.20+71.82%
27 qtrssince 2018-Q4
Decreased
0

MICROSOFT CORP

79.5M$39.5B6.8%$121.64+306.29%
27 qtrssince 2018-Q4
Increased
62

META PLATFORMS INC-CLASS A

24.6M$18.1B3.1%$166.04+341.18%
27 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL C

92.1M$16.3B2.8%$107.73+65.22%
27 qtrssince 2018-Q4
Decreased
0

PHILIP MORRIS INTERNATIONAL

88.3M$16.1B2.8%$64.87+173.96%
27 qtrssince 2018-Q4
Decreased
0

NVIDIA CORP

97.1M$15.3B2.6%$118.63+32.96%
19 qtrssince 2020-Q4
Decreased
0

AMAZON.COM INC

61.3M$13.4B2.3%$146.40+52.53%
27 qtrssince 2018-Q4
Decreased
0

GENERAL ELECTRIC CO COM STOCK

47.6M$12.2B2.1%$69.90+262.72%
12 qtrssince 2022-Q3
Increased
55

APPLE INC

52.4M$10.7B1.8%$166.64+22.53%
27 qtrssince 2018-Q4
Decreased
0

ROYAL CARIBBEAN CRUISES LTD

32.6M$10.2B1.8%$100.85+204.92%
25 qtrssince 2019-Q2
Increased
51

MASTERCARD INC - A

17.4M$9.8B1.7%$331.02+65.56%
27 qtrssince 2018-Q4
Increased
50

TRANSDIGM GROUP INC

6.2M$9.5B1.6%$301.33+365.51%
27 qtrssince 2018-Q4
Decreased
0

CONSTELLATION ENERGY - W/I

28.2M$9.1B1.6%$103.14+209.71%
14 qtrssince 2022-Q1
Decreased
0

ABBOTT LABORATORIES

60.1M$8.2B1.4%$80.54+64.32%
27 qtrssince 2018-Q4
Decreased
0

RAYTHEON TECHNOLOGIES CORP

55.9M$8.2B1.4%$73.28+95.48%
22 qtrssince 2020-Q1
Increased
52

JPMORGAN CHASE & CO

28.1M$8.2B1.4%$98.15+188.42%
27 qtrssince 2018-Q4
Decreased
0

VISA INC-CLASS A SHARES

21.3M$7.6B1.3%$177.97+97.57%
27 qtrssince 2018-Q4
Increased
50

ELI LILLY & CO

9.4M$7.3B1.3%$402.89+91.85%
27 qtrssince 2018-Q4
Decreased
0
WELLWELL
REIT

WELLTOWER INC

44.7M$6.9B1.2%$91.96+64.03%
11 qtrssince 2022-Q4
Increased
53

NORTHROP GRUMMAN CORP

12M$6B1.0%$344.01+42.46%
27 qtrssince 2018-Q4
Increased
65
$580.6B
AUM
443
Positions
Q2 2025
Filing
Rating · 3.0
Quarterly Portfolio Change
+11%Q1'24$493.9B-2%Q2'24$485.7B+7%Q3'24$521B+2%Q4'24$532.3B-4%Q1'25$508.5B+14%Q2'25$580.6B
Activity profile
$ moved · Q2'25
New4%Increased43%Decreased49%Exited3%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.8 years
<1Q5%1-4Q11%1-2Y15%2Y+69%

Capital International Investors manages $580.6B across 443 positions as of Q2 2025. Top holdings: AVGO (7.2%), MSFT (6.8%), META (3.1%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3/5.0.

Q2 2025 Summary

Active quarter - 34 new positions, 32 exits, 201 increased. Top move: NOC (INCREASED, conviction 65). Portfolio: $580.6B across 443 positions.

Top holdings by portfolio weight

Total AUM$581B
AVGO7.18%
MSFT6.81%
META3.12%
GOOG2.82%
PM2.77%
NVDA2.64%
AMZN2.32%
GE2.11%
AAPL1.85%
RCL1.76%
Other1.69%

Portfolio allocation by GICS sector

Sectors11
Technology28.10%
Industrials13.22%
Financial Services13.13%
Communication Services10.54%
Consumer Cyclical9.14%
Healthcare9.10%
Consumer Defensive5.69%
Utilities3.92%
Real Estate2.20%
Energy2.11%
Other2.86%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Industrials, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Solid(3.0 / 5.0)
Track Record51
Conviction45
Concentration47
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
APHAPHAMPHENOL CORP-CL A
Q3 2024 Q2 2026+39.8M shares+$7.4B
8Q
CGCPCGCPCAPITAL GRP FIXED INCM ETF T
Q3 2024 Q2 2026+64.7M shares+$1.4B
8Q
CA14020Y508CAPITAL GRP FIXED INCM ETF T
Q3 2024 Q2 2026+41.7M shares+$1.1B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used